Elevance Health Inc. (ELV)
Elevance Health Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Elevance Health Inc. (ELV) is a Medical - Healthcare Plans company based in US with a market capitalization of $85.3B. Revenue grew 12.6% year-over-year and the company generated $3.2B in free cash flow. This page tracks ELV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 104.2K employees · IPO Oct 30, 2001
Valuation
Valuation & price
$392.68as of May 17, 2026· -8.0% vs 52w high
15.4
P/E ratio
Latest-FY diluted EPS
1.94
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$85.3B
Market cap
12.6%
Revenue growth (YoY)
25.6%
Gross margin
$3.2B
Free cash flow (USD)
$23.7B
Net debt
-4.8%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last reported: Jul 15, 2026 (EPS $7.45)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider buyJul 17, 2026Filing
Insider Buy $366KPERU RAMIRO G · Director · $366.1K
- Insider buyJul 17, 2026Filing
Insider Buy $1.0MBOUDREAUX GAIL · Director, President and CEO · $1M
- Quarterly reportJul 15, 2026Filing
10-Q Filed
- 8-K eventJul 15, 2026Filing
Earnings Release
- Insider sellJun 15, 2026Filing
Insider Sell $149KPenczek Ronald W · CAO & Controller · $148.8K
- Insider sellJun 12, 2026Filing
Insider Sell $61KDixon Robert L JR · Director · $60.7K
- 8-K eventJun 10, 2026Filing
Earnings Guidance Reaffirmed
- Insider sellMay 20, 2026Filing
Insider Sell $617KPenczek Ronald W · CAO & Controller · $617.2K
- 8-K eventMay 13, 2026Filing
Annual Meeting Results
- 8-K eventApr 22, 2026Filing
Earnings Release
Questions
Frequently asked questions
What is Elevance Health Inc.'s market cap?
Elevance Health Inc. (ELV) has a market capitalization of $85.3B.
What is ELV's P/E ratio?
ELV trades at a price-to-earnings ratio of 15.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is ELV's price-to-book (P/B) ratio?
ELV trades at 1.94 times book value per share.
When did Elevance Health Inc. last report earnings?
ELV last reported earnings on July 15, 2026; the next date is not yet scheduled.
Are insiders buying ELV stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 3 sells at Elevance Health Inc. in the last 90 days.
Same arena
Related companies in Medical - Healthcare Plans
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.